Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein. [electronic resource]
Producer: 20021129Description: 5727-35 p. digitalISSN:- 0008-5472
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antigens, CD -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- B7-2 Antigen
- CD4-Positive T-Lymphocytes -- drug effects
- CD8-Positive T-Lymphocytes -- drug effects
- Cancer Vaccines -- immunology
- Combined Modality Therapy
- Female
- Immunoglobulin G -- administration & dosage
- Indoles -- administration & dosage
- Interferon-gamma -- biosynthesis
- Lymphocyte Activation -- drug effects
- Lymphocytes, Tumor-Infiltrating -- drug effects
- Mammary Neoplasms, Experimental -- blood supply
- Membrane Glycoproteins -- administration & dosage
- Mice
- Mice, Inbred BALB C
- Neoplasm Metastasis
- Oxindoles
- Propionates
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Spleen -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.